Featured Image for Epygenix Therapeutics
First Canadian Participant Dosed in ARGUS Trial, A Phase 2 Potentially Pivotal Study of EPX-100 Treatment of Dravet Syndrome
01 juin 2022 04h00 HE | Epygenix Therapeutics
PARAMUS, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Epygenix Therapeutics, a clinical-stage biopharmaceutical company focused on genetically screening, discovering and developing safe, effective and...
Adv_Logo_Stacked_7x2 (1).jpg
Argus Sells Private Placement Life Insurance Business to Advantage Insurance
27 juin 2018 08h00 HE | Advantage Insurance Inc.
HAMILTON, Bermuda, June 27, 2018 (GLOBE NEWSWIRE) -- The Argus Group today announces the sale of its private placement life business, which includes Argus International Life Bermuda Limited and its...
Naresh-Mandava-surgery-bionic-eye_006
UCHealth Eye Center Restores Limited Sight to Blind Patient with Region's First Bionic Eye Surgery
10 déc. 2015 09h10 HE | UCHealth
AURORA, Colo., Dec. 10, 2015 (GLOBE NEWSWIRE) -- The UCHealth Eye Center at University of Colorado Hospital has performed the first "bionic eye" procedure in the Rocky Mountain region, restoring...
Judicial Watch Obtains Records Detailing Obama Administration's Warrantless Collection of Citizens' Personal Financial Data
27 juin 2013 14h07 HE | Judicial Watch
WASHINGTON, DC--(Marketwired - Jun 27, 2013) - Judicial Watch announced today that it has obtained records from the Consumer Financial Protection Bureau (CFPB) revealing that the agency has spent...